GlassScriptPhysician profile
Felicia Hall
NPI 1316163157
$1,768.19
in general payments reported to CMS, 2019-2025
20 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $710 · 2020: $746 · 2021: $64.08 · 2022: $100 · 2024: $27.81 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $147.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $250.08 | 2019-2022 | |
| Janssen Biotech, INC. | $235.96 | 2019-2025 | Tremfya |
| Merz North America, INC. | $187.85 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $153.94 | 2019-2020 | |
| Lilly USA, LLC | $140.87 | 2019-2020 | |
| Galderma Laboratories, L.P. | $108.15 | 2019-2025 | Nemluvio |
| Vyne Pharmaceuticals INC. | $102.58 | 2020 | |
| Abbvie INC. | $99.51 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $89.77 | 2019-2020 | |
| Genzyme Corporation | $61.71 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $51.40 | 2019-2020 | |
| Allergan, INC. | $49.66 | 2019 | |
| Biofrontera INC. | $43.65 | 2020 | |
| Almirall LLC | $36.90 | 2019-2020 | |
| Sandoz INC. | $35.64 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $30.06 | 2020 | |
| Ucb, INC. | $26.56 | 2025 | Bimzelx |
| Dermira, INC. | $22.79 | 2020 | |
| Leo Pharma INC. | $21.37 | 2019 | |
| Botanix Sb INC | $19.74 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felicia Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.